πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 40 of 78

  1. US 8901093

    Custom vectors for treating and preventing pancreatic cancer

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8900818

    Recombinant antigen for diagnosis and prevention of murine typhus

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8900599

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8895521

    Methods and compositions for the treatment of uveitis

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8895018

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8883448

    Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8877765

    Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8877199

    B cell surface reactive antibodies

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8877213

    Live attenuated Leishmania vaccines

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8877914

    Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8871789

    Method of preventing or treating viral infection

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8871191

    Use of IL-15 preparations to treat lymphopenia

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8871906

    Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8871902

    Immunogenic POTE peptides and methods of use

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8865880

    Identification of a novel BHD gene

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8865461

    Rabies virus vector systems and compositions and methods thereof

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8865672

    Prevention of tissue ischemia and related methods

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8859284

    Delivery of nanoparticles to neurons

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8859585

    Scopolamine for the treatment of depression and anxiety

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8858959

    Gel vaccine delivery system for treating poultry

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8858946

    Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8858930

    Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8859207

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8853277

    Nitroxide therapy for the treatment of von Hippelβ€”Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8853160

    GLP-1, exendin-4, peptide analogs and uses thereof

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8852598

    Puumala virus full-length M segment-based DNA vaccines

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8852605

    Vibrio cholerae O139 conjugate vaccines

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8846051

    Modulation of replicative fitness by deoptimization of synonymous codons

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8846056

    Anti-RSV immunogens and methods of immunization

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8846057

    Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8846055

    Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8846389

    AAV4 vector and uses thereof

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8841266

    Pharmaceutical composition and method for regulating abnormal cellular proliferation

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8841305

    Activators of the human pyruvate kinase M2 receptor

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8835613

    Ξ²-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8835172

    Modular functional peptides for delivery of nanoparticles

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8835167

    Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8835378

    Multi-domain amphipathic helical peptides and methods of their use

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8828936

    Therapeutic use of SCGB3A2

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8829022

    N-substituted indenoisoquinolines and syntheses thereof

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8828717

    Framework residue substituted humanized COL-1 antibodies and their use

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8822434

    Compositions and methods to treat cardiac diseases

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.